Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03063203 · TERMINATED
Trial details
- NCT number
- NCT03063203
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-14
- Primary completion
- 2021-02-13
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.